Cart
sales@molnova.com
Home - Products - Others - Other Targets - Eubulus-A80

Eubulus-A80

CAS No. 2703776-20-7

Eubulus-A80( —— )

Catalog No. M35360 CAS No. 2703776-20-7

Eubulus-A80 is a anti-tumor agent (WO2021/183702, Compound A80).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 472 In Stock
2MG 278 In Stock
5MG 426 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Eubulus-A80
  • Note
    Research use only, not for human use.
  • Brief Description
    Eubulus-A80 is a anti-tumor agent (WO2021/183702, Compound A80).
  • Description
    GPX4-IN-8 (compound A80) is a potent GPX4 inhibitor. GPX4-IN-8 shows antiproliferative activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2703776-20-7
  • Formula Weight
    396.87
  • Molecular Formula
    C22H21ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(C#C)=O)(C1(C(NCC2=CC=CC=C2)=O)CCOCC1)C3=CC(Cl)=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sheldon Cao, et al. Gpx4 inhibitors, pharmaceutical compositions thereof, and their use for treating gpx4-mediated diseases. WO2021183702A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Egg yolk phosphatidy...

    Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.

  • BCPA

    BCPA is a non-cytotoxic Pin1 modulator.BCPA modulates osteoclast activation and attenuates the reduction of Pin1 protein, thereby inhibiting RANKL-induced receptor activators of osteoclastogenesis.BCPA is used in the study of osteoporosis.

  • VU 0357017 hydrochlo...

    VU 0357017 hydrochloride is highly selective M1 agonists act at an allosteric site to activate the receptor (EC50: 477 ± 172 nM; Pec50: 6.37 ± 0.15).

Sign In Join Free